JWH-018 binds to both equally the CB1 and CB2 receptors. The consequences of JWH-018 are primarily attributable into the binding and activation of CB1 receptors. In follow, the compound suppresses the release of neurotransmitters while in the central nervous procedure, which points out the multitude